Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zoran Popmihajlov, Lei Pang, Elizabeth Brown, Amita Joshi, Shu-Chih Su, Susan S. Kaplan & English D. Willis. (2018) A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL). Human Vaccines & Immunotherapeutics 14:12, pages 2916-2920.
Read now
Read now
Miguel Cordero-Coma, Raquel Salazar-Méndez, Irene Garzo-García & Taygan Yilmaz. (2015) Drug-induced uveitis. Expert Opinion on Drug Safety 14:1, pages 111-126.
Read now
Read now
Giovanni Gabutti, Elisabetta Franco, Paolo Bonanni, Michele Conversano, Antonio Ferro, Marzia Lazzari, Stefania Maggi, Alessandro Rossi, Silvestro Scotti, Francesco Vitale, Antonio Volpi & Donato Greco. (2015) Reducing the burden of Herpes Zoster in Italy. Human Vaccines & Immunotherapeutics 11:1, pages 101-107.
Read now
Read now
Hung Q Doan, Bothland Ung, Marigdalia K Ramirez-Fort, Farhan Khan & Stephen K Tyring. (2013)
Zostavax: a subcutaneous vaccine for the prevention of herpes zoster. Expert Opinion on Biological Therapy 13:10, pages 1467-1477.
Read now
Read now
Himal Lal, Toufik Zahaf & Thomas Heineman. (2013) Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su). Human Vaccines & Immunotherapeutics 9:7, pages 1425-1429.
Read now
Read now
Articles from other publishers (32)
Juliana de Oliveira Gomes, Anna MZ Gagliardi, Brenda NG Andriolo, Maria Regina Torloni, Regis B Andriolo, Maria Eduarda dos Santos Puga & Eduardo Canteiro Cruz. (2023) Vaccines for preventing herpes zoster in older adults. Cochrane Database of Systematic Reviews 2023:10.
Crossref
Crossref
Jean Li-Kim-Moy, Anastasia Phillips, Adelaide Morgan, Catherine Glover, Sanjay Jayasinghe, Brynley P Hull, Aditi Dey, Frank H Beard, Megan Hickie & Kristine Macartney. (2023) Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020. BMJ Open 13:1, pages e067287.
Crossref
Crossref
Myron J. Levin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1334
1349.e7
.
Simona Scalabrin, Alice Becco, Alessio Vitale & Raffaele Nuzzi. (2022) Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2. Frontiers in Medicine 9.
Crossref
Crossref
Yue Xia, Xue Zhang, Liuren Zhang & Chuanxi Fu. (2022) Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis. Frontiers in Immunology 13.
Crossref
Crossref
Courtney Gidengil, Matthew Bidwell Goetz, Sydne Newberry, Margaret Maglione, Owen Hall, Jody Larkin, Aneesa Motala & Susanne Hempel. (2021) Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine 39:28, pages 3696-3716.
Crossref
Crossref
Anastasia Phillips, Catherine Glover, Alan Leeb, Patrick Cashman, Parveen Fathima, Nigel Crawford, Thomas L Snelling, David Durrheim & Kristine Macartney. (2021) Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ Open 11:3, pages e043880.
Crossref
Crossref
James Totterdell, Anastasia Phillips, Catherine Glover, Kendal Chidwick, Julie Marsh, Tom Snelling & Kristine Macartney. (2020) Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia’s MedicineInsight program. Vaccine 38:23, pages 3968-3979.
Crossref
Crossref
Anna MZ Gagliardi, Brenda NG Andriolo, Maria Regina Torloni, Bernardo GO Soares, Juliana de Oliveira Gomes, Regis B Andriolo & Eduardo Canteiro Cruz. (2019) Vaccines for preventing herpes zoster in older adults. Cochrane Database of Systematic Reviews 2019:11.
Crossref
Crossref
Ashleigh McGirr, Robyn Widenmaier, Desmond Curran, Emmanuelle Espié, Tomas Mrkvan, Lidia Oostvogels, Benedetto Simone, Janet E. McElhaney, Heather Burnett, Katrin Haeussler, Adriana Thano, Xuan Wang & Rachel S Newson. (2019) The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis. Vaccine 37:22, pages 2896-2909.
Crossref
Crossref
Laura P. Hurley, Mandy A. Allison, Kathleen L. Dooling, Sean T. O'Leary, Lori A. Crane, Michaela Brtnikova, Brenda L. Beaty, Jessica A. Allen, Angela Guo, Megan C. Lindley & Allison Kempe. (2018) Primary care physicians’ experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV). Vaccine 36:48, pages 7408-7414.
Crossref
Crossref
Andrea C Tricco, Wasifa Zarin, Roberta Cardoso, Areti-Angeliki Veroniki, Paul A Khan, Vera Nincic, Marco Ghassemi, Rachel Warren, Jane P Sharpe, Andrea V Page & Sharon E Straus. (2018) Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ, pages k4029.
Crossref
Crossref
Myron J. Levin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1268
1281.e6
.
English D. Willis, Meredith Woodward, Elizabeth Brown, Zoran Popmihajlov, Patricia Saddier, Paula W. Annunziato, Neal A. Halsey & Anne A. Gershon. (2017) Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Vaccine 35:52, pages 7231-7239.
Crossref
Crossref
. (2017) Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 60:10, pages 1162-1179.
Crossref
Crossref
Michael N. Oxman & Ruth Harbecke. 2017. Herpes Zoster: Postherpetic Neuralgia and Other Complications. Herpes Zoster: Postherpetic Neuralgia and Other Complications
365
418
.
Giovanni Gabutti, Nicoletta Valente, Parvanè Kuhdari, Silvia Lupi & Armando Stefanati. (2016) Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. Journal of Medical Microbiology 65:12, pages 1363-1369.
Crossref
Crossref
Esther Redondo Margüello, Dídac Mauricio, José Javier Mediavilla Bravo, Alfonso Soto González, Elías Delgado Álvarez, F. Javier Ampudia-Blasco & Esteban Jódar Gimeno. (2016) ZODIAC: Consenso para la prevención del herpes zóster en personas con diabetes mellitus. SEMERGEN - Medicina de Familia 42, pages 1-19.
Crossref
Crossref
Huifeng Yun, Shuo Yang, Lang Chen, Fenglong Xie, Kevin Winthrop, John W. Baddley, Kenneth G. Saag, Jasvinder Singh & Jeffrey R. Curtis. (2016) Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. Arthritis & Rheumatology 68:9, pages 2328-2337.
Crossref
Crossref
Anna MZ Gagliardi, Brenda NG Andriolo, Maria Regina Torloni & Bernardo GO Soares. (2016) Vaccines for preventing herpes zoster in older adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Nabila Ferahta, Imene Achek, Julie Dubourg & Pierre-Olivier Lang. (2016) Les vaccins contre le zona : efficacité, sécurité, et rapport coût/bénéfices. La Presse Médicale 45:2, pages 162-176.
Crossref
Crossref
P. Loulergue & O. Launay. (2015) Vaccination contre le zona. Journal des Anti-infectieux 17:3, pages 115-119.
Crossref
Crossref
P.-O. Lang & C. Trivalle. (2015) Le vaccin contre le zona : vos questions et leurs réponses. NPG Neurologie - Psychiatrie - Gériatrie 15:88, pages 200-205.
Crossref
Crossref
Stefania Maggi, Giovanni Gabutti, Elisabetta Franco, Paolo Bonanni, Michele Conversano, Antonio Ferro, Marzia Lazzari, Alessandro Rossi, Silvestro Scotti, Francesco Vitale, Antonio Volpi & Donato Greco. (2015) Preventing and managing herpes zoster: key actions to foster healthy aging. Aging Clinical and Experimental Research 27:1, pages 5-11.
Crossref
Crossref
Kent B. Crossley & Phillip K. Peterson. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3459
3465.e3
.
Pierre-Olivier Lang & Richard Aspinall. (2014) Vaccination in the Elderly: What Can Be Recommended?. Drugs & Aging 31:8, pages 581-599.
Crossref
Crossref
J. Ruiz-Aragón, M. García-Cenoz, S. Márquez-Peláez & C. Navarro Palenzuela. (2014) Evaluación de la vacuna para la prevención del herpes zóster en adultos: revisión sistemática de la literatura. Vacunas 15:1-2, pages 13-20.
Crossref
Crossref
. (2013) Herpes Zoster. New England Journal of Medicine 369:18, pages 1765-1767.
Crossref
Crossref
Gillian M. Keating. (2013) Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review of Its Use in the Prevention of Herpes Zoster and Postherpetic Neuralgia in Adults Aged ≥50 Years. Drugs 73:11, pages 1227-1244.
Crossref
Crossref
Charles W. Hwang, Walter A. Steigleman, Erika Saucedo-Sanchez & Sonal S. Tuli. (2013) Reactivation of Herpes Zoster Keratitis in an Adult After Varicella Zoster Vaccination. Cornea 32:4, pages 508-509.
Crossref
Crossref
Anna MZ Gagliardi, Brenda Nazaré Gomes Silva, Maria R Torloni & Bernardo GO Soares. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Roger Baxter, Trung Nam Tran, John Hansen, Michael Emery, Bruce Fireman, Joan Bartlett, Ned Lewis & Patricia Saddier. (2012) Safety of Zostavax™—A cohort study in a managed care organization. Vaccine 30:47, pages 6636-6641.
Crossref
Crossref